Tenoscope
by Luxtec Corp.
510(k) K970642
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK970642 | Date21 May 1997 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- HRX
- Device Class
- Class II
- Regulation
- 21 CFR Part 888.1100
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The Tenoscope is a diagnostic device classified as an orthopedic instrument designed for visualizing and assessing tendon integrity. It is specifically intended for identifying severed tendons that have retracted within their sheath, where non-invasive retrieval methods have failed.
This device is supplied as a reusable medical instrument and is intended for use in clinical settings where tendon visualization is required. It has received FDA 510(k) clearance under the HRX product code and is regulated as a substantially equivalent orthopedic device. No additional sterility or MRI safety specifications are noted in the available data.
Other devices from Luxtec Corp.
Questions
AI-generated answers, 19 Sep 2026
What clinical situations is the Tenoscope designed to address specifically?
The Tenoscope is intended for visualizing and assessing tendon integrity in cases where tendons have been severed and retracted within their sheath, making them difficult to locate using non-invasive retrieval methods. It is particularly useful in orthopedic settings where traditional techniques have failed to identify the tendon’s location.
Is the Tenoscope meant for single-use or can it be reused in multiple procedures?
The Tenoscope is explicitly supplied as a reusable medical instrument, meaning it is designed for repeated use in clinical settings after proper cleaning and maintenance. There are no notes in the available data indicating it requires single-use or has sterility requirements beyond standard reusable orthopedic instrument protocols.
How was the Tenoscope’s regulatory pathway determined, and what does that mean for its use?
The Tenoscope was classified as substantially equivalent to a predicate device under the FDA’s 510(k) process, specifically under the HRX product code (Orthopedic Instruments). This means its safety and effectiveness were compared to an existing device already on the market, and it received clearance in 1997. Clinically, this pathway confirms it meets FDA standards for orthopedic visualization tools without requiring additional approvals beyond its original clearance.
Who should I contact if I need more details about the Tenoscope’s specifications or support?
For inquiries regarding the Tenoscope, you can reach Luxtec Corp. through their listed contact, Joseph Ress, at their Newton, MA office (45 Pontiac Rd., 02168). This is the official applicant and manufacturer for the device, as noted in the FDA submission records.